1. Home
  2. APYX vs CRBP Comparison

APYX vs CRBP Comparison

Compare APYX & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.70

Market Cap

128.0M

Sector

Health Care

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.97

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
CRBP
Founded
1982
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.0M
134.8M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
APYX
CRBP
Price
$3.70
$8.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$6.50
$45.60
AVG Volume (30 Days)
99.6K
185.5K
Earning Date
03-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$6.22
N/A
Revenue Next Year
$6.74
$99.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$0.83
$4.64
52 Week High
$4.50
$20.56

Technical Indicators

Market Signals
Indicator
APYX
CRBP
Relative Strength Index (RSI) 52.48 52.49
Support Level $3.25 $8.80
Resistance Level $4.32 $9.69
Average True Range (ATR) 0.25 0.67
MACD 0.05 0.08
Stochastic Oscillator 59.60 46.63

Price Performance

Historical Comparison
APYX
CRBP

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: